Objective. The goal of this study was to assess the relationship between ov
ulation induction, nulliparity, and ovarian epithelial dysplasia.
Methods. This retrospective cohort study was performed in one teaching and
one district general hospital in London. The subjects, 83 women who had und
ergone hysterectomy and bilateral oophorectomy and whose ovaries were repor
ted as "normal," were divided into three groups: ovulation induction (13),
nulliparity (20), and fertile controls (50). These ovaries were independent
ly reviewed by two pathologists who assigned a score of 0, 1, or 2 to nine
epithelial cytological and architectural features. The main outcome measure
was the total dysplasia score, which was used to quantify the degree of ov
arian epithelial abnormality in the three groups.
Results. The mean dysplasia score was significantly higher in the women who
had undergone ovulation induction than in the fertile controls (7.92 vs 5.
70, P = 0.012). The magnitude of the difference between the ovulation induc
tion group and controls remained similar after adjusting for age, parity, a
nd duration of oral contraceptive use (2.17, 95% CI: -0.11-4.44). However,
the statistical significance of this difference was reduced (P = 0.062). We
did not find any evidence of a difference in dysplasia score between nulli
parous women and controls, neither before (P = 0.85) nor after adjusting fo
r age and duration of oral contraceptive use (P = 0.87).
Conclusions. These results suggest a possible association between ovarian e
pithelial dysplasia and ovulation induction therapy, in accord with previou
s reports of increased risk of ovarian cancer in women with a history of fe
rtility treatment. The higher dysplasia score could be attributable to the
drugs used to induce ovulation or to a genetic susceptibility to ovarian ca
ncer. (C) 2001 Academic Press.